Weiss v. Banner Health ( 2021 )


Menu:
  •                                                                                   FILED
    United States Court of Appeals
    UNITED STATES COURT OF APPEALS                          Tenth Circuit
    FOR THE TENTH CIRCUIT                          February 9, 2021
    _________________________________
    Christopher M. Wolpert
    Clerk of Court
    JENNIFER M. WEISS,
    Plaintiff - Appellant/Cross -
    Appellee,
    Nos. 19-1384 & 19-1418
    v.                                             (D.C. No. 1:17-CV-00443-DDD-NYW)
    (D. Colo.)
    BANNER HEALTH,
    Defendant - Appellee/Cross -
    Appellant.
    _________________________________
    ORDER AND JUDGMENT *
    _________________________________
    Before HARTZ, KELLY, and PHILLIPS, Circuit Judges.
    _________________________________
    Plaintiff-Appellant Jennifer Weiss appeals from the district court’s decision
    upholding Defendant-Appellee Banner Health’s (“Banner”) denial of her request for
    pre-authorization of knee surgery. Weiss v. Banner Health, 
    416 F. Supp. 3d 1178
     (D.
    Colo. 2019). Banner cross-appeals from the district court’s denial of its motion to
    dismiss the suit as barred under the Health and Welfare Benefit Plan’s contractual
    provision requiring such claims to be filed within a year of Banner’s final decision
    *
    This order and judgment is not binding precedent, except under the doctrines
    of law of the case, res judicata, and collateral estoppel. It may be cited, however, for
    its persuasive value consistent with Fed. R. App. P. 32.1 and 10th Cir. R. 32.1.
    denying coverage. Aplt. App. 20. Exercising jurisdiction under 
    28 U.S.C. § 1291
    ,
    we affirm.
    Background
    Ms. Weiss worked for Banner as an ICU nurse and was covered by the Banner
    Health Master Health and Welfare Benefit Plan (“the Plan”). In 2013, Ms. Weiss
    began experiencing knee pain and sought treatment from an orthopedic surgeon
    employed by Banner. After initial treatments failed, Ms. Weiss was referred to
    another orthopedic surgeon to assess the need for Autologous Chondrocyte
    Implantation (ACI), a surgical alternative to knee replacement. The surgeon
    requested that Banner preauthorize the ACI procedure for coverage under the Plan.
    The Plan excludes from coverage treatments that are “not Medically
    Necessary” and defines “Medically Necessary” as “medically proven to be effective
    treatment of the condition.” The Plan provides that, in determining whether a
    treatment is medically proven to be effective, the plan administrator will consider
    Banner’s Summary Plan Description (the “SPD”), the claimant’s medical records,
    and authoritative medical literature, among other things. It also grants Banner sole
    authority to determine whether a procedure is experimental or investigative based on
    prevailing medical evidence.
    Banner denied the request for preauthorization. In reaching this conclusion,
    Banner relied on the Milliman Care Guidelines’ (MCG) conclusion that evidence
    regarding the efficacy of ACI in treating the type of injury from which Ms. Weiss
    2
    suffered was “insufficient, conflicting, or poor.” Ms. Weiss appealed this decision
    internally. Pursuant to the procedure under the Plan, Banner selected an orthopedic
    surgeon to review Ms. Weiss’s claim. The surgeon concluded that he would approve
    the procedure based on Ms. Weiss’s medical history and a review of relevant medical
    literature but could not address the contractual issues of Ms. Weiss’s claim. Banner
    issued an Appeal Notice of Denial Determination upholding its original denial and
    reiterating that the procedure was not covered under the Plan based on the MCG.
    The notice did not inform Ms. Weiss that any civil action challenging this final
    internal decision must be filed within one year.
    Ms. Weiss next opted to pursue a voluntary external appeal, which was
    conducted by Medical Review Institute of America (MRI). In a letter dated February
    20, 2015, MRI upheld Banner’s denial of coverage, concluding that the studies
    supporting ACI’s efficacy did not satisfy the Plan’s medical necessity requirement.
    On February 17, 2017, Ms. Weiss filed an action challenging Banner’s denial
    of coverage under Section 502(a)(1)(B) of the Employee Retirement Income Security
    Act (ERISA). Banner moved to dismiss the claim as barred by the Plan’s one-year
    contractual limitations period for civil actions. The district court denied Banner’s
    motion. Banner’s failure to inform Ms. Weiss of the contractual limitations period in
    the Appeal Notice of Denial Determination, as required under the SPD, precluded
    Banner from relying on the limitations period to dismiss the action. The parties filed
    a joint motion for determination, which the district court granted and issued an order
    upholding Banner’s denial of Ms. Weiss’s claim. Ms. Weiss appeals from that
    3
    decision and Banner cross-appeals from the district court’s denial of its motion to
    dismiss.
    Analysis
    A. Contractual Limitations Period
    Banner contends that the district court erred in denying its motion to dismiss
    based on its failure to notify Ms. Weiss of the one-year contractual limitations period
    because the notification requirement applied only to the first level appeal and not to
    the external review. We interpret a plan governed by ERISA de novo. Dang v.
    UNUM Life Ins. Co. of Am., 
    175 F.3d 1186
    , 1189 (10th Cir. 1999).
    ERISA identifies two categories of documents — the plan document, “which
    must specify in writing the basis on which payments are to be made under the plan,”
    and the SPD, “which must reasonably apprise participants of their rights and
    obligations under the plan.” Holmes v. Colo. Coal. for the Homeless Long Term
    Disability Plan, 
    762 F.3d 1195
    , 1199 (10th Cir. 2014). The terms contained in an
    SPD are not inherently enforceable. CIGNA Corp. v. Amara, 
    563 U.S. 421
    , 437
    (2011). However, an SPD can be enforceable as part of the plan itself when, for
    example, “the SPD clearly [states] on its face that it is part of the Plan,” Eugene S. v.
    Horizon Blue Cross Blue Shield of N.J., 
    663 F.3d 1124
    , 1131 (10th Cir. 2011), and
    the SPD terms to be enforced do not conflict with the Plan. Holmes, 762 F.3d at
    1200.
    4
    Because ERISA does not specify a limitations period for filing suit, ERISA-
    governed plans often “fill[] that gap” by specifying a contractual limitations period,
    which is enforceable as long as it is reasonable. Heimeshoff v. Hartford Life &
    Accident Ins. Co., 
    571 U.S. 99
    , 102 (2013). Here, the Plan contains a one-year
    contractual limitations period. The SPD informs Plan participants that any written
    notice of decision denying an internal appeal will provide participants notice of this
    limitations period by explaining their right to bring a civil action within one year of
    receipt of the denial. The SPD also states that it is “incorporated into and part of [the
    Plan],” and is therefore enforceable as part of the Plan itself. See Eugene S., 
    663 F.3d at 1131
    .
    Banner contends that the notice requirement applies only to decisions on
    internal appeals, not those reached through the external appeals process. Thus, the
    notice requirement does not apply to Banner’s decision denying benefits after Ms.
    Weiss’s external appeal. That may be so. However, it is ultimately beside the point
    because, as the district court noted and as Banner itself concedes, its notice of
    decision denying Ms. Weiss’s internal appeal also did not include notice of her right
    to bring a civil action within a year of the decision as required under the SPD. Ms.
    Weiss’s choice to pursue the voluntary external review process did not relieve
    Banner of its obligation to notify Ms. Weiss of her right to pursue a civil action
    within one year of the internal appeal denial. That procedural requirement is
    enforceable against Banner. See Holmes, 762 F.3d at 1203. The district court
    5
    correctly denied Banner’s motion to dismiss Ms. Weiss’s claim as barred by the
    contractual limitations period.
    Banner also argues that the district court erred in applying a six-year statute of
    limitations to Ms. Weiss’s claims. The district court relied on Held v. Mfrs. Hanover
    Leasing Corp., 
    912 F.2d 1197
     (10th Cir. 1990), in concluding that the applicable
    statute of limitations was six years. As Banner notes, the court in Held applied New
    York law, rather than Colorado law, which both parties agree applies here. See 
    id. at 1203
    . However, we have noted in an unpublished decision that the statute of
    limitations for ERISA claims is also six years under Colorado law. Lee v. Rocky
    Mountain UFCW Unions and Emps. Tr. Pension Plan, No. 92-1308, 
    1993 WL 482951
    , at *1 n.2 (10th Cir. Nov. 23, 1993). And even if Ms. Weiss’s claims were
    subject to a two-year statute of limitations as Banner contends, her claim was filed
    within two years of the final decision on the external appeal.
    B. Denial of Benefits
    Ms. Weiss challenges the district court’s decision upholding Banner’s denial
    of benefits. Where a plan grants the plan administrator discretionary authority to
    determine eligibility for benefits, the administrator’s decision will be overturned only
    if it is arbitrary and capricious. Van Steen v. Life Ins. Co. of N. Am., 
    878 F.3d 994
    ,
    996–97 (10th Cir. 2018). We review a district court’s determination of whether an
    ERISA benefits decision is arbitrary and capricious de novo. Id. at 996.
    Ms. Weiss argues that Banner’s denial was arbitrary and capricious because it
    was motivated by Banner’s conflict of interest in serving as both the sponsor and
    6
    administrator of the Plan and was based on Banner’s treatment of the MCG as
    dispositive, to the exclusion of other evidence supporting the efficacy of ACI.
    A single entity’s dual role as both sponsor and administrator of an ERISA-
    governed plan creates a conflict of interest that a reviewing court will consider as one
    factor in determining whether the plan administrator abused its discretion in denying
    benefits. Metro. Life Ins. Co. v. Glenn, 
    554 U.S. 105
    , 108 (2008). We have
    interpreted Glenn “to embrace a combination-of-factors method of review,” in which
    case-specific factors are weighed together in evaluating whether the benefits decision
    amounts to an abuse of discretion. Graham v. Hartford Life & Accident Ins. Co., 
    589 F.3d 1345
    , 1358 (10th Cir. 2009) (quotations omitted). The weight a conflict of
    interest receives under this method “is proportionate to the likelihood that the conflict
    affected the benefits decision.” 
    Id.
    Ms. Weiss argues that the severity of Banner’s conflict of interest is
    demonstrated by its failure to notify her of the contractual limitations period and
    subsequent attempt to dismiss her claim based on the limitations period. She
    identifies no other facts that would suggest the conflict of interest is particularly
    likely to have affected the benefits decision. While the conflict of interest inherent in
    Banner’s dual roles as Plan sponsor and administrator decreases the level of
    deference to which its decision is entitled and is one factor to consider in reviewing
    Banner’s decision, it does not itself establish that the decision was arbitrary and
    capricious. See Rekstad v. U.S. Bancorp, 
    451 F.3d 1114
    , 1120 (10th Cir. 2006).
    7
    Taking the conflict of interest into account, Banner’s decision was not
    arbitrary and capricious. The Plan states that it will consider “[a]uthoritative medical
    literature” in determining whether a treatment is medically necessary and grants
    Banner sole authority to determine a treatment is experimental or investigative based
    on “prevailing medical evidence.” And while the Plan does not expressly identify
    MCG among the non-exhaustive list of sources it will consider, the MCG are used by
    numerous hospitals to make clinical decisions and “were written and reviewed by
    over 100 doctors and reference 15,000 medical sources.” Norfolk Cnty. Ret. Sys. v.
    Cmty. Health Sys., Inc., 
    877 F.3d 687
    , 690 (6th Cir. 2017). The MCG guideline
    applicable to ACI concludes that evidence supporting ACI’s efficacy in treating Ms.
    Weiss’s injury “is insufficient, conflicting, or poor.” This conclusion is supported by
    20 citations to medical literature. Under the terms of the Plan, Banner could
    reasonably rely on the MCG’s conclusion in exercising its discretion to determine
    that reliable evidence indicated that ACI was not an effective treatment of Ms.
    Weiss’s injury.
    Ms. Weiss also argues that, even if Banner appropriately considered the MCG
    in reaching its decision, its failure to meaningfully consider the other available
    evidence constitutes an abuse of discretion. However, the record demonstrates that
    both the internal and external reviewers considered her entire appeal applications,
    including medical records and the opinions of the doctors that would have approved
    the procedure. “The Administrator’s decision need not be the only logical one nor
    even the best one,” and “will be upheld unless it is not grounded on any reasonable
    8
    basis.” Finley v. Hewlett-Packard Co. Emp. Benefits Org. Income Prot. Plan, 
    379 F.3d 1168
    , 1176 (10th Cir. 2004) (quoting Kimber v. Thiokol Corp., 
    196 F.3d 1092
    ,
    1098 (10th Cir. 1999)). Ms. Weiss has not shown that Banner’s decision lacked a
    reasonable basis.
    AFFIRMED.
    Entered for the Court
    Paul J. Kelly, Jr.
    Circuit Judge
    9